EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial Cardiolipin-Targeted Tetrapeptide, SS-31, Exerts Neuroprotective Effects Within In Vitro and In Vivo Models of Spinal Cord Injury

Baylen Ravenscraft, Do-Hun Lee iD, Heqiao Dai, Abbie Lea Watson, Gabriela Inés Aparicio, Xianlin Han iD, Ling-Xiao Deng iD, Nai-Kui Liu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Baylen Ravenscraft und 7 weiteren Autor:innen. Beteiligte Einrichtung: Indiana Spinal Cord and Brain Injury Research Group, Stark Neurosciences Research Institute, Department of Neurological Surgery, Indiana University S…. Hauptthemen laut MEDLINE: Cardiolipins, Spinal Cord Injuries, Mitochondria, Neuroprotective Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Veterans Affairs, The Craig H Neilsen Foundation, Indiana Spinal Cord and Brain Injury Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI) affects millions globally, leading to severe motor and sensory deficits with no effective clinical treatment. Cardiolipin (CL), a mitochondria-specific phospholipid, plays a critical role in bioenergetics and apoptosis. Emerging evidence suggests that CL alterations contribute to secondary SCI pathology, but their precise role and underlying mechanisms remain fully understudied. In this study, we investigated the protective effects of SS-31 on CL alteration, neuronal death, tissue damage, and behavioral recovery after SCI using both in vitro and in vivo models, lipidomics analysis, histological evaluation, and behavioral assessments. In vitro investigations used primary spinal cord neuron cultures, challenged with either rotenone or glutamatergic excitotoxicity, with protective capabilities measured via cell death assays and neurite morphological analysis. In vivo investigations used female adult C57Bl/6 mice, challenged with a contusive SCI. The results showed that SS-31 reduced rotenone- and glutamate-induced mitochondrial dysfunction and neuronal death in a dose-dependent manner in vitro. Additionally, SS-31 attenuated rotenone- and glutamate-induced neurite degeneration in vitro. Lipidomics analysis revealed a reduction in CL at 24 h post-SCI in adult mice, which was attenuated by SS-31 in a dose-dependent manner. Consistent with this effect, SS-31 improved behavioral recovery after SCI in adult mice, although it had no significant effect on tissue damage. These findings suggest that CL alteration may play a key role in the pathogenesis of SCI, at least in the C57BL/6 mouse, and as such could be an attractive therapeutic target for ameliorating secondary SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiolipinsSpinal Cord InjuriesMitochondriaNeuroprotective AgentsOligopeptidesAnimalsMiceFemaleMice, Inbred C57BLDisease Models, AnimalNeuronsGlutamic AcidRotenoneCells, Cultured

Stichwörter der Autor:innen

SS-31cardiolipinlipidmitochondrial functionneuroprotectionspinal cord injury

Substanzen

CardiolipinsNeuroprotective Agentsarginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamideOligopeptidesGlutamic AcidRotenone

Autor:innen und Institutionen

  • Indiana Spinal Cord and Brain Injury Research Group, Stark Neurosciences Research Institute, Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA.
  • Neurorestoration Center, Department of Neurosurgery, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
  • Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

ORCID-Profile: Do-Hun Lee, Xianlin Han, Ling-Xiao Deng, Nai-Kui Liu

Förderung

  • U.S. Department of Veterans Affairs
  • The Craig H Neilsen Foundation
  • Indiana Spinal Cord and Brain Injury Research Foundation
  • NIH HHS
  • NIA NIH HHS
  • BLRD VA
  • NINDS NIH HHS
  • DOD

Zitieren

APA

Ravenscraft, B., Lee, D. H., Dai, H., Watson, A. L., Aparicio, G. I., Han, X., Deng, L. X., & Liu, N. K. (2025). Mitochondrial Cardiolipin-Targeted Tetrapeptide, SS-31, Exerts Neuroprotective Effects Within In Vitro and In Vivo Models of Spinal Cord Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073327

Vancouver

Ravenscraft B, Lee DH, Dai H, Watson AL, Aparicio GI, Han X, et al. Mitochondrial Cardiolipin-Targeted Tetrapeptide, SS-31, Exerts Neuroprotective Effects Within In Vitro and In Vivo Models of Spinal Cord Injury. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073327

BibTeX
@article{Ravenscraft2025,
  author = {Ravenscraft, Baylen and Lee, Do-Hun and Dai, Heqiao and Watson, Abbie Lea and Aparicio, Gabriela Inés and Han, Xianlin and Deng, Ling-Xiao and Liu, Nai-Kui},
  title = {Mitochondrial Cardiolipin-Targeted Tetrapeptide, SS-31, Exerts Neuroprotective Effects Within In Vitro and In Vivo Models of Spinal Cord Injury},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073327}
}
Kostenlos starten →